Mother-infant Signalling During Breastfeeding (MOMS)

July 10, 2018 updated by: University College, London

Mother-infant Signalling During Breastfeeding: A Randomised Trial Investigating the Effects of a Relaxation Intervention in Breastfeeding Mothers on Breast Milk Production, Breast Milk Cortisol and Infant Behaviour and Growth.

Primary hypotheses

1. The use of a relaxation tape by breastfeeding mothers that will be given starting at week 2 postpartum, will result in : i) reduced maternal stress and anxiety ii) the production of a higher volume of breast milk iii) lower milk cortisol concentrations iv) favourable effects on infant behaviour (less crying, more sleeping) v) higher milk intake by the infant vi) more optimal growth, specifically higher lean mass and lower fat mass (body composition)

Secondary hypotheses (i) Infant temperament/behaviour and gender influence milk and energy intake and hence early growth and body composition (ii) Non-nutrient factors in breast milk (hormones including ghrelin and leptin) influence infant behaviour and feeding patterns and hence infant growth and body composition.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kuala Lumpur, Malaysia
        • Faculty of Medicine and Health Science, Universiti Putra Malaysia (UPM).

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 40 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Primiparous mother with singleton pregnancy Infant is singleton and born at term (37-42 week of gestation) Infant birth weight of >2500 g (5,5 pounds or 5 pounds and 8,2 ounces) Mother and infant are generally healthy (free of serious illness that can affect breastfeeding or nursing infant, or energy balance of the infant).

No current or recent involvement in other research studies that could potentially affect any of outcome measures.

Mother speaks and understands either English only or English and Malay (some questionnaires are in English)

Exclusion Criteria:

Mother or baby has a major illness that affects nursing or breastfeeding, or affects energy balance of the infant.

Mother smokes Mothers who do not exclusively breastfeed their infant

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control
Breastfeeding mothers who are not randomised to relaxation intervention
Experimental: Relaxation
Breastfeeding mothers randomised to use relaxation tape at 2 weeks post-partum
Other Names:
  • Relaxation tape - audio tape with visual imagery and relaxation exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal stress and anxiety
Time Frame: Baselibne to 12 weeks
Maternal stress and anxiety assessed using the Cohen's Perceived Stress Scale (PSS) and Beck Anxiety Inventory (BAI) respectively (change in score from baseline to end-point at 12 weeks)
Baselibne to 12 weeks
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
Time Frame: 12 weeks
Breast milk volume at 12 weeks assessed non-invasively using stable isotope techniques
12 weeks
Breast milk cortisol concentrations at 12 weeks
Time Frame: 12 weeks
12 weeks
Infant behaviour measured using a 3-day diary at 12 weeks
Time Frame: 12 weeks
12 weeks
Infant weight and body composition measured using stable isotopes at 12 weeks
Time Frame: 12 weeks
12 weeks
Physiological changes (maternal saliva cortisol, breast milk cortisol and milk volume) before and after physiological-mini test in intervention group at 2,6 and 12 weeks.
Time Frame: 2,6,12 weeks
2,6,12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Non-nutrient factors in breast milk - leptin and ghrelin
Time Frame: 2,6,12 weeks
2,6,12 weeks
Macronutrient composition of breast milk (fat and protein)
Time Frame: 2,6,12 weeks
2,6,12 weeks

Other Outcome Measures

Outcome Measure
Time Frame
Infant temperament measured using the Rothbart questionnaire
Time Frame: 12 weeks
12 weeks
Infant appetite assessed using the BEBQ
Time Frame: 2,6,12 weeks
2,6,12 weeks
Maternal depression assessed using Edinburgh Postnatal Depression Scale (EPDS)
Time Frame: 2 weeks
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mary Fewtrell, MD, UCL Institute of Child Health, London

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2013

Primary Completion (Actual)

March 1, 2015

Study Completion (Actual)

January 1, 2017

Study Registration Dates

First Submitted

October 23, 2013

First Submitted That Met QC Criteria

October 23, 2013

First Posted (Estimate)

October 29, 2013

Study Record Updates

Last Update Posted (Actual)

July 12, 2018

Last Update Submitted That Met QC Criteria

July 10, 2018

Last Verified

July 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 13NT05

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Breastfeeding Women

Clinical Trials on Relaxation

3
Subscribe